Related scientific articles (all)

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Authors : Azim HA, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart-Gebhart M, Dougall WC, Pruneri G, Sotiriou C
Year : 2015
Journal : Breast Cancer Res
Volume : 17
Pages : 24

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial.

Authors : Sonnenblick A, Brohée S, Fumagalli D, Rothé F, Vincent D, Ignatiadis M, Desmedt C, Salgado R, Sirtaine N, Loi S, Neven P, Loibl S, Denkert C, Joensuu H, Piccart-Gebhart M, Sotiriou C
Year : 2015
Journal : Oncotarget
Volume : 6
Pages : 30306-16

Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.

Authors : Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M
Year : 2015
Journal : Tumori
Volume : 101 Suppl 1
Pages : 0

Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Authors : Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H, Li Y, Ju YS, Ramakrishna M, Haugland HK, Lilleng PK, Nik-Zainal S, McLaren S, Butler A, Martin S, Glodzik D, Menzies A, Raine K, Hinton J, Jones D, Mudie LJ, Jiang B, Vincent D, Greene-Colozzi A, Adnet PY, Fatima A, Maetens M, Ignatiadis M, Stratton MR, Sotiriou C, Richardson AL, Lønning PE, Wedge DC, Campbell PJ
Year : 2015
Journal : Nat. Med.
Volume : 21(7)
Pages : 751-9

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Authors : Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, + collaborators (among others :, Dal Lago L, de Azambuja E, Dabakuyo-Yonli TS
Year : 2015
Journal : Ann Oncol
Volume : 26(5)
Pages : 873-879.

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.

Authors : Ignatiadis M, Lee M, Jeffrey SS
Year : 2015
Journal : Clin Cancer Res
Volume : 21
Pages : 4786-800

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Authors : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Year : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pages : 448-54

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up.

Authors : Dallaudière B, Kerger J, Malghem J, Galant C, Lecouvet FE
Year : 2015
Journal : Acta Radiol Open
Volume : 4(2)
Pages : 2047981614552217

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

Authors : Fumagalli D, Gacquer D, Rothé F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, Larsimont D, Polyak K, Willard-Gallo K, Desmedt C, Piccart-Gebhart M, Abramowicz M, Campbell PJ, Sotiriou C, Detours V
Year : 2015
Journal : Cell Rep
Volume : 13
Pages : 277-89

Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.

Authors : Twelves C, Cortes J, Vahdat L, Olivo M, He Y, Kaufman PA, Awada A
Year : 2015
Journal : Breast Cancer Res. Treat.
Volume : 149(1)
Pages : 313

Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma.

Authors : Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelholm JL, Gomez Galdon M, Deleporte A, Hendlisz A, Vanderlinden B, Flamen P, Donckier V
Year : 2015
Journal : World J Gastroenterol
Volume : 21
Pages : 9666-70

Evolving paradigms in multifocal breast cancer.

Authors : Salgado R, Aftimos P, Sotiriou C, Desmedt C
Year : 2015
Journal : Semin. Cancer Biol.
Volume : 31C
Pages : 111-118

The landscape of medical oncology in Europe by 2020.

Authors : de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M
Year : 2014
Journal : Ann Oncol
Volume : 25(2)
Pages : 525-8

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Authors : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C
Year : 2014
Journal : Ann Oncol
Volume : 25(10)
Pages : 1871-88

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Authors : Ignatiadis M, Dawson SJ
Year : 2014
Journal : Ann Oncol
Volume : 25(12)
Pages : 2304-2313

Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.

Authors : Aftimos P, Barthelemy P, Awada A
Year : 2014
Journal : Discov Med
Volume : 17(92)
Pages : 81-91

Words matter: distinguishing personalized medicine" and "biologically personalized therapeutics"."

Authors : Cherny NI, de Vries EG, Emanuel L, Fallowfield L, Francis PA, Gabizon A, Piccart-Gebhart M, Sidransky D, Soussan-Gutman L, Tziraki C
Year : 2014
Journal : J. Natl. Cancer Inst.
Volume : 106(12)

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Authors : Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, Van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S
Year : 2014
Journal : Lancet Oncol
Volume : 15(4)
Pages : 406-14

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

Authors : Popescu RA, Schäfer R, Califano R, Eckert R, Coleman R, Douillard JY, Cervantes A, Casali PG, Sessa C, van Cutsem E, De Vries E, Pavlidis N, Fumasoli K, Wörmann B, Samonigg H, Cascinu S, Cruz Hernández JJ, Howard AJ, Ciardiello F, Stahel RA, Piccart-Gebhart M
Year : 2014
Journal : Ann Oncol
Volume : 25(1)
Pages : 9-15

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Authors : Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart-Gebhart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA
Year : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 808-15